About Nabla
Nabla is a company based in Boston (United States) founded in 2020 by Frances Anastassacos and Surge Biswas. It operates as a AI-as-a-Service, and Professional Services. Nabla has raised $37 million across 3 funding rounds from investors including Khosla Ventures, Radical Ventures and Zetta Venture Partners. Nabla offers products and services including Antibody Design Platform. Nabla operates in a competitive market with competitors including Proteros, Biomatter, Fina Biosolutions, Peak Proteins and Crelux, among others.
- Headquarter Boston, United States
- Founders Frances Anastassacos, Surge Biswas
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nabla Bio, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$37 M (USD)
in 3 rounds
-
Latest Funding Round
$26 M (USD), Series A
May 14, 2024
-
Investors
Khosla Ventures
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nabla
Nabla offers a comprehensive portfolio of products and services, including Antibody Design Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibodies are designed with AI and experimental technologies.
Unlock access to complete
Unlock access to complete
Funding Insights of Nabla
Nabla has successfully raised a total of $37M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $26.0M
-
First Round
First Round
(01 Apr 2021)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Nabla | Valuation | Radical Ventures |
|
| Dec, 2021 | Amount | Seed - Nabla | Valuation | Khosla Ventures , Zetta Venture Partners | |
| Apr, 2021 | Amount | Grant - Nabla | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nabla
Nabla has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Radical Ventures and Zetta Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on AI-driven companies
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Seed and early-stage tech investments are made in the US.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nabla
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nabla
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nabla Comparisons
Competitors of Nabla
Nabla operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proteros, Biomatter, Fina Biosolutions, Peak Proteins and Crelux, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery services are provided to researchers in protein biochemistry.
|
|
| domain | founded_year | HQ Location |
Provider of synthetic biology and AI-based technology for generative protein design
|
|
| domain | founded_year | HQ Location |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| domain | founded_year | HQ Location |
Protein expression, purification, and structural biology services are provided.
|
|
| domain | founded_year | HQ Location |
X-ray crystallography and fragment-based drug discovery services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nabla
Frequently Asked Questions about Nabla
When was Nabla founded?
Nabla was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Nabla located?
Nabla is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Nabla?
Surge Biswas is the current CEO of Nabla. They have also founded this company.
Is Nabla a funded company?
Nabla is a funded company, having raised a total of $37M across 3 funding rounds to date. The company's 1st funding round was a Grant of $256K, raised on Apr 01, 2021.
What does Nabla do?
Nabla is engaged in developing integrated AI and experimental technologies for drug design. The company is based in Cambridge, MA, and focuses on creating generative models and multiplexed screens for antibody design. Solutions are targeted at challenging disease targets like GPCRs and ion channels. Partnerships with leading pharmaceutical companies are established to maximize impact. The integration of AI-guided design with wet-lab experimentation is emphasized to enhance manufacturability, safety, and efficacy of drugs for complex diseases.
Who are the top competitors of Nabla?
Nabla's top competitors include Proteros, Fina Biosolutions and Biomatter.
What products or services does Nabla offer?
Nabla offers Antibody Design Platform.
Who are Nabla's investors?
Nabla has 6 investors. Key investors include Khosla Ventures, Radical Ventures, Zetta Venture Partners, Fifty Years, and Cantos Ventures.